Search Results - "Loken, Jesper"

Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: A randomized trial by Jensen, Jens U, Hein, Lars, Lundgren, Bettina, Bestle, Morten H, Mohr, Thomas T, Andersen, Mads H, Thornberg, Klaus J, Løken, Jesper, Steensen, Morten, Fox, Zoe, Tousi, Hamid, Søe-Jensen, Peter, Lauritsen, Anne Ø, Strange, Ditte, Petersen, Pernille L, Reiter, Nanna, Hestad, Søren, Thormar, Katrin, Fjeldborg, Paul, Larsen, Kim M, Drenck, Niels E, Østergaard, Christian, Kjær, Jesper, Grarup, Jesper, Lundgren, Jens D

“…OBJECTIVE:For patients in intensive care units, sepsis is a common and potentially deadly complication and prompt initiation of appropriate antimicrobial…”
Get full text

The potential of antimicrobials to induce thrombocytopenia in critically ill patients: data from a randomized controlled trial by Johansen, Maria Egede, Jensen, Jens-Ulrik, Bestle, Morten Heiberg, Hein, Lars, Lauritsen, Anne Øberg, Tousi, Hamid, Larsen, Kim Michael, Løken, Jesper, Mohr, Thomas, Thormar, Katrin, Johansson, Pär I, Cozzi-Lepri, Alessandro, Lundgren, Jens D

“…Antimicrobial-induced thrombocytopenia is frequently described in the literature among critically ill patients. Several antimicrobials have been implicated,…”
Get full text

Predicting recovery from acute kidney injury in critically ill patients: development and validation of a prediction model by Itenov, Theis S, Berthelsen, Rasmus Ehrenfried, Jensen, Jens-Ulrik, Gerds, Thomas A, Pedersen, Lars M, Strange, Ditte, Thormar, Katrin, Løken, Jesper, Andersen, Mads H, Tousi, Hamid, Reiter, Nanna, Lundgren, Jens D, Bestle, Morten H

“…Objective: Intensive care unit (ICU) patients with acute kidney injury (AKI) who recover kidney function within 28 days experience less severe chronic kidney…”
Get full text

Kidney failure related to broad-spectrum antibiotics in critically ill patients: secondary end point results from a 1200 patient randomised trial by Jensen, Jens-Ulrik Stæhr, Hein, Lars, Lundgren, Bettina, Bestle, Morten Heiberg, Mohr, Thomas, Andersen, Mads Holmen, Thornberg, Klaus Julius, Løken, Jesper, Steensen, Morten, Fox, Zoë, Tousi, Hamid, Søe-Jensen, Peter, Lauritsen, Anne Øberg, Strange, Ditte Gry, Reiter, Nanna, Thormar, Katrin, Fjeldborg, Paul Christian, Larsen, Kim Michael, Drenck, Niels-Erik, Johansen, Maria Egede, Nielsen, Lene Ryom, Østergaard, Christian, Kjær, Jesper, Grarup, Jesper, Lundgren, Jens D

“…ObjectivesTo explore whether a strategy of more intensive antibiotic therapy leads to emergence or prolongation of renal failure in intensive care…”
Get full text

The Procalcitonin And Survival Study (PASS) - a randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker Procalcitonin and pro-active diagnostic and therapeutic responses to abnormal Procalcitonin levels, can improve survival in intensive care unit patients. Calculated sample size (target population): 1000 patients by Jensen, Jens-Ulrik, Lundgren, Bettina, Hein, Lars, Mohr, Thomas, Petersen, Pernille L, Andersen, Lasse H, Lauritsen, Anne O, Hougaard, Sine, Mantoni, Teit, Bømler, Bonnie, Thornberg, Klaus J, Thormar, Katrin, Løken, Jesper, Steensen, Morten, Carl, Peder, Petersen, J Asger, Tousi, Hamid, Søe-Jensen, Peter, Bestle, Morten, Hestad, Søren, Andersen, Mads H, Fjeldborg, Paul, Larsen, Kim M, Rossau, Charlotte, Thomsen, Carsten B, Ostergaard, Christian, Kjaer, Jesper, Grarup, Jesper, Lundgren, Jens D

“…Sepsis and complications to sepsis are major causes of mortality in critically ill patients. Rapid treatment of sepsis is of crucial importance for survival of…”
Get full text

Prediction of non-recovery from ventilator-demanding acute respiratory failure, ARDS and death using lung damage biomarkers: data from a 1200-patient critical care randomized trial by Jensen, Jens-Ulrik S., Itenov, Theis S., Thormar, Katrin M., Hein, Lars, Mohr, Thomas T., Andersen, Mads H., Løken, Jesper, Tousi, Hamid, Lundgren, Bettina, Boesen, Hans Christian, Johansen, Maria E., Ostrowski, Sisse R., Johansson, Pär I., Grarup, Jesper, Vestbo, Jørgen, Lundgren, Jens D.

“…Background It is unclear whether biomarkers of alveolar damage (surfactant protein D, SPD) or conductive airway damage (club cell secretory protein 16, CC16)…”
Get full text

Invasive Candida Infections and the Harm From Antibacterial Drugs in Critically Ill Patients: Data From a Randomized, Controlled Trial to Determine the Role of Ciprofloxacin, Piperacillin-Tazobactam, Meropenem, and Cefuroxime by Jensen, Jens-Ulrik S, Hein, Lars, Lundgren, Bettina, Bestle, Morten H, Mohr, Thomas, Andersen, Mads H, Løken, Jesper, Tousi, Hamid, Søe-Jensen, Peter, Lauritsen, Anne Ø, Strange, Ditte, Petersen, John A, Thormar, Katrin, Larsen, Kim M, Drenck, Niels-Erik, Helweg-Larsen, Jannik, Johansen, Maria E, Reinholdt, Kristian, Møller, Jens K, Olesen, Bente, Arendrup, Maiken C, Østergaard, Christian, Cozzi-Lepri, Alessandro, Grarup, Jesper, Lundgren, Jens D

“…OBJECTIVE:Use of antibiotics in critically ill patients may increase the risk of invasive Candida infection. The objective of this study was to determine…”
Get full text

The Procalcitonin And Survival Study : 1000 patients by Jensen, Jens-Ulrik, Lundgren, Bettina, Hein, Lars, Mohr, Thomas, Petersen, Pernille L, Andersen, Lasse H, Lauritsen, Anne O, Hougaard, Sine, Mantoni, Teit, Bomler, Bonnie, Thornberg, Klaus J, Thormar, Katrin, Loken, Jesper, Steensen, Morten, Carl, Peder, Petersen, J Asger, Tousi, Hamid, Soe-Jensen, Peter, Bestle, Morten, Hestad, Soren, Andersen, Mads H, Fjeldborg, Paul, Larsen, Kim M, Rossau, Charlotte, Thomsen, Carsten B, Ostergaard, Christian, Kjaer, Jesper, Grarup, Jesper, Lundgren, Jens D

Get full text

Non-recognized Liver Impairment in Infected Critically Ill Patients Is Frequent and Hazardous by Jensen, Jens Ulrik, Peters, Lars, Johansen, Maria Egede, Itenov, Theis Skovsgaard, Bestle, Morten, Lauritsen, Anne Øberg, Mohr, Thomas, Thormar, Katrin, Løken, Jesper, Søe-Jensen, Peter, Christensen, Per Hjort, Andersen, Mads Holmen, Lundgren, Bettina, Grarup, Jesper, Lundgren, Jens

Get full text

886Non-recognized Liver Impairment in Infected Critically Ill Patients Is Frequent and Hazardous by Jensen, Jens Ulrik, Peters, Lars, Johansen, Maria Egede, Itenov, Theis Skovsgaard, Bestle, Morten, Lauritsen, Anne Øberg, Mohr, Thomas, Thormar, Katrin, Løken, Jesper, Søe-Jensen, Peter, Christensen, Per Hjort, Andersen, Mads Holmen, Lundgren, Bettina, Grarup, Jesper, Lundgren, Jens

Get full text

The Procalcitonin And Survival Study (PASS) – A Randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker Procalcitoninand pro-active diagnostic and therapeutic responses to abnormal Procalcitonin levels, can improve survival in intensive care unit patients. Calculated sample size (target population): 1000 patients by Jensen, Jens-Ulrik, Lundgren, Bettina, Hein, Lars, Mohr, Thomas, Petersen, Pernille L, Andersen, Lasse H, Lauritsen, Anne Ø, Hougaard, Sine, Mantoni, Teit, Bømler, Bonnie, Thornberg, Klaus J, Thormar, Katrin, Løken, Jesper, Steensen, Morten, Carl, Peder, Petersen, J Asger, Tousi, Hamid, Søe-Jensen, Peter, Bestle, Morten, Hestad, Søren, Andersen, Mads H, Fjeldborg, Paul, Larsen, Kim M, Rossau, Charlotte, Thomsen, Carsten B, Østergaard, Christian, Kjær, Jesper, Grarup, Jesper, Lundgren, Jens D

Get full text